Возможности политропной терапии тиотриазолином у пациентов с неалкогольным стеатогепатозом и сердечно-сосудистыми факторами риска. Результаты наблюдательной программы «ТРИГОН –1»

The article presents the results of the section of the multicenter Observation program TRIGON initiated by the Gastroenterology Scienti fi c Society of Russia (GSSR). The aim of the TRIGON-1 study was to study the mechanisms of comorbidity formation in patients with non-alcoholic steatohepatosis and predictors of cardiovascular diseases (CVD) and the e ff ect of multi-organ therapy on this. Over the course of two months, 30 patients with non-alcoholic steatohepatosis and predictors of CVD development who received thiotriazoline monotherapy were observed. It is shown that the formation of mechanisms of comorbidity of NAFLD and cardiovascular diseases occurs at the early stages of the development of these su ff erings. Course monotherapy with drug multiple organ action - thiotriazoline in patients with NAFLD improves liver health and reduces the risk of CVD.